BGB-10188
BGB-A317-3111-10188-101
Phase 2 small_molecule completed
Quick answer
BGB-10188 for Chronic Lymphocytic Leukemia is a Phase 2 program (small_molecule) at BeOne Medicines with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BeOne Medicines
- Indication
- Chronic Lymphocytic Leukemia
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed